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Abstract
Background: Hospitals are increasingly being evaluated with respect to the quality of provided care. In this
setting, several indicator sets compete with one another for the assessment of effectiveness and safety. However,
there have been few comparative investigations covering different sets. The objective of this study was to answer
three questions: How concordant are different indicator sets on a hospital level? What is the effect of applying
different reference values? How stable are the positions of a hospital ranking?
Methods: Routine data were made available to three companies offering the Patient Safety Indicators, an indicator
set from the HELIOS Hospital Group, and measurements based on Disease Staging™. Ten hospitals from North
Rhine-Westphalia, comprising a total of 151,960 inpatients in 2006, volunteered to participate in this study. The
companies provided standard quality reports for the ten hospitals. Composite measures were defined for strengths
and weaknesses. In addition to the different indicator sets, different reference values for one set allowed the
construction of several comparison groups. Concordance and robustness were analyzed using the non-parametric
correlation coefficient and Kendall’sW .
Results: Indicator sets differing only in the reference values of the indicators showed significant correlations in
most of the pairs with respect to weaknesses (maximum r = 0.927, CI 0.714-0.983, p < 0.001). There were also
significant correlations between different sets (maximum r = 0.829, CI 0.417-0.958, p = 0.003) having different
indicators or when different methods for performance assessment were applied. The results were weaker
measuring hospital strengths (maximum r = 0.669, CI 0.068-0.914, p = 0.034). In a hospital ranking, only two
hospitals belonged consistently either to the superior or to the inferior half of the group. Even altering reference
values or the supplier for the same indicator set changed the rank for nine out of ten hospitals.
Conclusions: Our results reveal an unsettling lack of concordance in estimates of hospital performance when
different quality indicator sets are used. These findings underline the lack of consensus regarding optimal validated
measures for judging hospital quality. The indicator sets shared a common definition of quality, independent of
their focus on patient safety, mortality, or length of stay. However, for most of the hospitals, changing the indicator
set or the reference value resulted in a shift from the superior to the inferior half of the group or vice versa. Thus,
while taken together the indicator sets offer the hospitals complementary pictures of their quality, on an individual
basis they do not establish a reliable ranking.
Background
Several quality indicator sets are on the market that
measure and assess the quality of hospital acute care
provided for inpatients. Quality indicator sets offer sev-
eral measures (the indicators), with a detailed definition
of inclusion and exclusion criteria, formulas for the
calculation of each measure, reference values, rules for
the frequency of analysis and reporting, as well as
recommendations for their appropriate usage. We
consider indicator sets not only as a collection of inde-
pendent measures, but also as a reliable approach to
assess quality at the level of the hospital itself or one of
its departments, its case groups, managed diseases, or
procedures. Individual measures are combined to yield a
score or another composite that reflects quality on an
aggregate level. The composites might be used, for
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policy makers and funders.
Literature reviews describe a remarkable number of
quality indicator sets, with minor and major overlaps.
The Organization for Economic Co-operation and
Development (OECD) analyzed six sources to establish
their indicators for patient safety at the health systems
level [1,2]. The German Advisory Council on the
Assessment of Developments in the Health Care System
published a report in 2007 on “Cooperation and
Responsibility. Prerequisites for Target-Oriented Health
Care” [3], with a major focus on quality indicator sets
addressing patient safety. The report discusses at least
20 different sets, e.g. the Health Care Quality Indicator
set of the OECD, proposals from the US Agency for
Healthcare Research and Quality (AHRQ) and from the
Joint Commission on Accreditation of Healthcare Orga-
nizations, and several national programs, especially in
European countries. However, there is little evidence on
the effective application of quality indicator sets.
According to Glattacker and Jäckel, the evaluation of
quality assurance programs yields results that are “con-
sistently inconsistent,” especially concerning the effect
on patients’ outcome [4]. A recent review of the effec-
tive implementation of quality indicators in hospital care
identified 21 studies [5]. In most of these, the effects on
care processes were evaluated and significant improve-
ments were reported, whereas others determined inef-
fective results concerning patient outcome. Regarding
integrated quality management models, Minkmann et al.
concluded, “that there is weak evidence for improved
performance” for two out of the three models reviewed
in their study [6]. Fung et al. carried out a systematic
review of the effect of publicly reported performance
data on clinical outcomes and concluded, “The useful-
ness of public reporting in improving safety and patient-
centeredness remains unknown” [7]. It is not surprising,
that O’Leary et al. called for the need to “revisit the
quality measures currently used for transparency and
incentives” [8].
The quality of quality indicators collected in a set is a
separate topic. The aim to be RUMBA (cited from [9]), i.
e., relevant, understandable, measurable, behavioral, and
achievable, is not reached by most of the popular quality
indicators, e.g. with respect to hospital mortality [10].
The variety of quality indicator sets, the increasing
usage of different sets in Germany, as well as the weak
evidence of their usefulness motivated the Hospital
Association of North Rhine-Westphalia to establish the
“Quality Assessment with Routine Data” project, the
aim of which was to obtain a specific quality indicator
set based on routine data and targeted for use in Ger-
man hospitals. Reliable results, no additional workload
for data acquisition, and high acceptance by clinicians
were the acceptance criteria for the recommended
approach. The indicator set should support the hospitals
in their negotiations with health insurance funds and
other institutions. As part of this project, we analyzed
the concordance and robustness of the included quality
indicator sets. Specifically, we were interested in answer-
ing three questions: (1) How concordant are different
indicator sets on a hospital level? (2) What is the effect
of applying different reference values? (3) How stable
are the positions of a hospital ranking? The answers to
these questions are of fundamental importance for the
application of quality indicator sets in accreditation,
contracting, and public reporting issues.
Methods
Project
After a call for participation, three companies signed a
contract to participate in the project: 3 M Health Infor-
mation Systems (abbreviated as 3 M), InMed GmbH
(InMed) and Schellen & Partner (Deutschland) GmbH
(SP). Ten hospitals in Germany voluntarily provided
routine data from 2006. With a mean of 15,196 (stan-
dard deviation 7,967), these hospitals serve more inpati-
ents per hospital than German hospitals in general, with
a mean of 10,521 inpatients [11].
The routine data included administrative information
as well as diagnoses and procedures coded with the leg-
islatively required classifications. The German modifica-
tion of the International Statistical Classification of
Diseases and Related Health Problems 10th Revision
(ICD-10-GM) is used for the coding of primary and sec-
ondary diagnoses; a national procedure classification is
used for the coding of operative and non-operative pro-
cedures. Outcome is defined as discharge status living/
dead. As the data were anonymized for inpatients as
well as for the hospitals, ethical approval of the study
was not necessary.
The three companies were expected to deliver
standard quality reports within a 3-month period. The
deliverables of the companies included the following
measures:
￿ Second-generation quality indicator set of the
HELIOS Hospital Group [12], a private operator of
more than 60 hospitals in Germany (3 M and
InMed); see also http://www.helios-kliniken.de/medi-
zin/qualitaetsmanagement/transparenz/qualitaets-
kennzahlen.html for information in German.
￿ Patient Safety Indicators (PSI) of the AHRQ in ver-
sion 2.1, revision 3 (3 M) [13]; see also http://www.
qualityindicators.ahrq.gov/Modules/psi_overview.
aspx.
￿ Analyses based on Disease Staging™ version IV
from Medstat Group Inc (SP) [14]. Two manuals are
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Nationwide Inpatient Sample at http://www.hcup-us.
ahrq.gov/db/nation/nis/nisdbdocumentation.jsp.
The second-generation quality indicator set of the
HELIOS Hospital Group comprises 78 indicators (e.g.
“myocardial infarction mortality rate, age <45”)o r g a -
nized in 31 subcategories (e.g. “myocardial infarction”)
and nine categories (e.g. “diseases of the heart”). Fifty-
eight indicators report mortality rates, ten indicators are
volume oriented. The PSI count adverse events that
could harm the patient. Version 2.1 contains 23 indica-
tors for the evaluation of hospitals. Only two indicators
measure mortality. 3 M further divided PSI 4 “failure to
rescue” into six particular complications of care, which
were also included in this study. Thus, the final PSI set
comprised 29 indicators, including eight mortality rates.
Disease Staging is a system for the classification of inpa-
tients in disease categories [15]. First, patients are classi-
fied in so-called disease categories (DXCat, e.g.
“infective endocarditis”). Second, severity of illness is
used to define several stages (maximum of five, from
normal to death) according to the “risk of organ failure
or death.” SP uses DXCat and stages as homogeneous
groups for an assessment by SP experts. The reports by
SP include a sample of DXCat according to the fre-
quency or importance of the disease category.
Measurements
Composite measures of weaknesses and strengths were
calculated for each hospital (cf. method in [16]). To
address weaknesses, each indicator result was categor-
ized as inconspicuous or conspicuous by comparing its
value to a reference range, provided by either the indica-
tor sets or the companies (yes/no decision). A reference
range was established based on a reference value (i.e. a
threshold) and a direction for better results. In addition,
the number of conspicuous indicator results was divided
by the sum of inconspicuous and conspicuous indicator
results for each indicator set within each hospital (i.e.
relative proportion of conspicuous indicators). Indicators
without a reference range were excluded. To address
strengths, each indicator result was categorized as best
practice or not. An indicator result received the status
of best practice if the hospital was the best in class, or
among one of the 20% best. In addition, the number of
best practice indicator results was divided by the sum of
best practice and not best practice indicator results for
each indicator set within each hospital (i.e. relative pro-
portion of best practice indicator results).
3 M offered two different reference values for the
HELIOS indicator set, the rate calculated from the
merged data of all ten hospitals (denoted in this article
as “3 M HELIOS group”)a n dat a r g e tv a l u ep u b l i s h e d
by the HELIOS Hospital Group (3 M HELIOS target)
[17]. InMed offered four different references: (1) target
value published by the HELIOS Hospital Group (InMed
HELIOS target), (2) target value published by the
HELIOS Hospital Group compared with confidence lim-
its of the observed rate (InMed HELIOS assessment),
(3) a rate calculated from the merged data of a bench-
marking data set from the company (InMed HELIOS
benchmarking) and (4) current rates published for the
HELIOS Hospital Group (InMed HELIOS rates).
InMed defines a confidence interval as follows: The
lower limit is defined by the rate calculated by subtract-
ing the number one from the numerator, the upper
limit by the rate calculated by adding the number one
to the numerator. An observed rate was conspicuous if
both lower and upper boundaries were outside the refer-
ence range defined by the target value published by the
HELIOS Hospital Group (InMed HELIOS assessment).
For PSI, 3 M uses the rate calculated from the merged
data of all ten hospitals as reference values (3 M PSI).
In contrast to 3 M and InMed, the deliverables of SP
included its own assessment of results within DXCat, as
established by means of Disease Staging software. The
assessment yielded a classification of the length of stay
(LOS) distribution using a textual ordinal scale (SP
LOS) and a classification of the mortality rate using a
color scale (SP Mort): white, yellow and red for incon-
spicuous, in between and conspicuous, respectively.
Table 1 provides an example of the calculation of the
percentage of conspicuous indicators for one hospital.
InMed and 3 M calculated the same mortality rate for
heart failure in patients age 65-84, i.e. 7.9%. This value
was within the confidence limit defined by InMed.
Thus, the indicator was rated as inconspicuous in the
group “InMed HELIOS assessment.” In the case of mor-
tality rates, better quality is indicated by lower values.
The observed rate of 7.9% was less than or equal to the
reference value of the groups “InMed HELIOS target”
(reference value 10.1%), “InMed HELIOS benchmarking”
(reference value 9.8%), “3MH E L I O St a r g e t ” (reference
value 10.1%) and “3 M HELIOS group” (reference value
10.5%). Thus, the indicator was rated as inconspicuous
for all four groups. However, the observed rate of 7.9%
was higher than the reference value of the group
“InMed HELIOS rates” (reference value 6.8%). Thus, the
indicator was rated as conspicuous for this group. In
summary, 8 of 15 indicators of hospital D (53.3%)
showed conspicuous results within the group “InMed
HELIOS rates.” The percentage of 53.3% was then used
as the composite measure for weaknesses.
Overall, each hospital was assigned a maximum of
nine composite measures to evaluate its weaknesses, six
based on a comparison of its results from the HELIOS
indicator set with six different reference values, one
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uate its strengths, each hospital was assigned four com-
posite measures, one for the HELIOS indicator set (3 M
values: 3 M HELIOS), one for the PSI (3 M values: 3 M
PSI), one for the mortality rate of SP within DXCat (SP
Mort), and an ordinal assessment by SP of the LOS dis-
tribution within DXCat (SP LOS).
Subsequently, the rank of each hospital within each of
the 13 comparison groups based on the composite mea-
sures was identified, resulting in 90 figures for the
assessment of weaknesses, i.e. ten hospitals with the
rankings obtained from nine different comparison
groups (six HELIOS, PSI, two Disease Staging™), and
40 figures for the assessment of strengths, i.e. ten hospi-
tals with the rankings of four different comparison
groups (HELIOS, PSI, two Disease Staging™).
Statistics
The non-parametric correlation coefficient was calcu-
lated according to Spearman in order to assess the con-
cordance of indicator sets. The 95% confidence interval
(CI) for the non-parametric correlation coefficient was
calculated using the formula presented by Altmann and
Gardner [18]. To evaluate the robustness of the indicator
sets, the ranks were analyzed using Kendall’sc o e f f i c i e n t
of concordance. Significance was assumed at p ≤ 0.05.
The data were managed using a database from Micro-
soft
® Access 2003. Correlation coefficients were calcu-
lated with SPSS
® 14.0, and Kendall’s coefficient of
concordance with SPSS
® 15.0.
Results
Three companies delivered reports for the ten hospitals.
Table 2 presents the correlation coefficients for the rela-
tive frequency of conspicuous indicator results. There
was a significant and substantial correlation between
most of the comparison groups covering the HELIOS
indicator set, with the highest correlation coefficient
(0.927) obtained for the comparison between the 3 M
HELIOS and InMed HELIOS targets (CI 0.714-0.983,
p < 0.001). The gap to one can be explained by differ-
ences either in the indicators calculated, in the indicator
results, or in the target values. The coefficients of the
other significant correlations from these comparison
groups were between 0.657 (CI 0.047-0.910, p = 0.039)
and 0.915 (CI 0.673-0.980, p < 0.001). There was no sig-
nificant correlation between the InMed HELIOS assess-
ment and the two comparison groups defined by 3 M.
Table 1 Example: Observed rates for 15 HELIOS indicators from hospital D
3 M InMed
Observed
rate
Reference value Observed
rate
Confidence
limits
Reference value
Category/subcategory/
indicator
Helios
target
Helios
group
Helios
target
Helios
rates
Benchmarking
Diseases of the heart: heart
attack
Mortality 7.7% 10.7% 9.5% 7.7% 7.6% - 7.9% 10.7% 8.5% 10.2%
Mortality age <45 0.0% 2.6% 0.9% 0.0% 0.0% - 4.2% 2.6% 1.5% 3.6%
Mortality age 45-64 2.6% 4.3% 3.7% 2.6% 2.1% - 3.1% 4.3% 2.9% 4.2%
Mortality age 65-84 9.9% 12.0% 12.1% 9.9% 9.6% - 10.2% 12.0% 9.2% 11.0%
Mortality age >84 15.8% 28.8% 20.8% 15.8% 14.3% - 17.2% 28.8% 23.1% 24.9%
Diseases of the heart: heart
failure
Mortality age >19 9.6% 11.4% 11.4% 9.6% 9.5% - 9.7% 11.4% 7.9% 11.0%
Mortality age 20-44 0.0% 4.1% 4.7% 0.0% 0.0% - 7.7% 4.1% 6,0% 4.0%
Mortality age 45-64 0.9% 5.3% 4.4% 0.9% 0.0% - 1.8% 5.3% 2,3% 4.8%
Mortality age 65-84 7.9% 10.1% 10.5% 7.9% 7.7% - 8.1% 10.1% 6,8% 9.8%
Mortality age >84 19.7% 18.4% 19.5% 19.7% 19.3% - 20.1% 18.4% 17.7% 17.8%
Stroke: all types
Mortality 19.1% 11.4% 11.8% 19.3% 18.7% - 19.9% 11.4% 10.0% 10.5%
Mortality age 20-44 0% 3.8% 2.9% 0.0% 0.0% - 50.0% 3.8% 2.3% 3.4%
Mortality age 45-64 9.1% 5.5% 6.3% 9.1% 0.0% - 16.7% 5.5% 5.4% 5.0%
Mortality age 65-84 16.7% 11.2% 11.5% 16.9% 15.9% - 17.9% 11.2% 9.7% 10.3%
Mortality age >84 26.7% 21.0% 24.2% 26.7% 25.0% - 28.3% 21.0% 17.6% 18.7%
Percentage conspicuous 33.3% 33.3% 26.7% 33.3% 53.3% 33.3%
Good quality is indicated by low rates for all indicators. Conspicuous results are in bold.
Three different percentages of conspicuous indicators are calculated: 26.7%, 33.3% and 53.3%. Compared with the other hospitals, hospital D received ranks 5, 3,
5, 4, 2 and 2 for the whole HELIOS indicator set.
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son group enhanced the differences between 3 M and
InMed in the basic numbers. The correlation between
SP Mort and SP LOS was not significant, whereas signif-
icant correlations were determined between SP Mort
and the InMed HELIOS assessment (r = 0.811, CI
0.371-0.954, p = 0.004), SP Mort and the InMed
HELIOS rates (r = 0.723, CI 0.171-0.930, p = 0.018),
and SP LOS and 3 M PSI (r = 0.829, CI 0.417-0.958,
p = 0.003). Most of the confidence intervals overlapped
with each other.
Kendall’s coefficient of concordance for all nine
groups was 0.598 (p < 0.001), and for the six groups
derived from HELIOS indicators 0.825 (p < 0.001).
Table 3 and Figure 1 show the ranks of each hospital.
According to the HELIOS indicator set, four of the
Table 2 Correlation coefficients for the relative frequency of conspicuous indicator results
HELIOS indicator set 3 M
PSI
SP
Mort
SP
LOS
3M
HELIOS
group
3M
HELIOS
target
InMed HELIOS
assessment
InMed HELIOS
benchmarking
InMed
HELIOS
rates
InMed
HELIOS
target
3 M HELIOS
group
Coefficient 0.867
(0.523-
0.968)
0.571
(-0.092-0.883)
0.903
(0.634-0.977)
0.855
(0.488-
0.965)
0.891
(0.595-0.974)
0.304
(-0.403-
0.784)
0.413
(-0.293-
0.827)
0.426
(-0.278-
0.832)
Sig. (2-
sided)
0.001 0.084 0.000 0.002 0.001 0.393 0.235 0.220
3 M HELIOS
target
Coefficient 0.559
(-0.109-0.879)
0.915
(0.673-0.980)
0.673
(0.075-
0.915)
0.927
(0.714-0.983)
0.000
(-0.630-
0.630)
0.292
(-0.414-
0.779)
0.085
(-0.575-
0.678)
Sig. (2-
sided)
0.093 0.000 0.033 0.000 1.000 0.413 0.815
InMed HELIOS
assessment
Coefficient 0.657
(0.047-0.910)
0.802
(0.348-
0.951)
0.693
(0.112-0.921)
0.405
(-0.302-
0.824)
0.811
(0.371-
0.954)
0.409
(-0.253-
0.810)
Sig. (2-
sided)
0.039 0.005 0.026 0.245 0.004 0.241
InMed HELIOS
benchmarking
Coefficient 0.855
(0.488-
0.965)
0.915
(0.673-0.980)
0.036
(-0.607-
0.651)
0.529
(-0.151-
0.869)
0.188
(-0.501-
0.731)
Sig. (2-
sided)
0.002 0.000 0.920 0.116 0.602
InMed HELIOS
rates
Coefficient 0.770
(0.272-0.943)
0.353
(-0.356-
0.804)
0.723
(0.171-
0.930)
0.547
(-0.126-
0.875)
Sig. (2-
sided)
0.009 0.318 0.018 0.102
InMed HELIOS
target
Coefficient 0.128
(-0.546-
0.701)
0.498
(-0.192-
0.858)
0.128
(-0.546-
0.701)
Sig. (2-
sided)
0.725 0.143 0.725
3 M PSI Coefficient 0.396
(-0.311-
0.821)
0.829
(0.417-
0.958)
Sig. (2-
sided)
0.257 0.003
SP Mort Coefficient 0.341
(-0.368-
0.799)
Sig. (2-
sided)
0.334
SP LOS Coefficient
Sig. (2-
sided)
The nine groups consist of 10 hospitals each.
95% confidence interval in parentheses.
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of the group and in others to the inferior half, depend-
ing on the comparison group. Three hospitals belonged
consistently to the superior half of the group, and three
consistently to the inferior half. Taking into account the
results from 3 M PSI, SP Mort and SP LOS as well,
only one hospital ranked consistently in the superior
group (hospital K) and two in the inferior group (hospi-
tals A and I). The median difference between the lowest
and highest rank per hospital was 5.25, with a minimum
of 1 and a maximum of 7. The range of the relative fre-
quency of conspicuous indicator results per HELIOS
comparison group was at least 31.5% (InMed HELIOS
group, minimum 30.8%, maximum 62.3%) and at most
47.7% (InMed HELIOS assessment, 0%, 47.7%). The
range was much higher for 3 M PSI, with 68.2% (0%,
68.2%), and for SP LOS, with 85.7% (0%, 85.7%), and
much lower for SP Mort, with 13.9% (0%, 13.9%). In the
latter case, the low number of conspicuous indicator
results, i.e. 26 from 655 (4.0%, 95% confidence interval
2.6%-5.8%), should be noted.
Table 4 presents the correlation coefficients of the
relative frequencies of best practice indicator results.
There were only two significant correlations, 3 M PSI
with SP Mort (r = 0.646, CI 0.028-0.907, p = 0.043) and
3 M PSI with SP LOS (r = 0.669, CI 0.068-0.914, p =
0.034). There was no significant correlation between the
two mortality-oriented indicator sets, 3 M HELIOS and
SP Mort (r = 0.576, CI -0.084-0.885, p = 0.082). In gen-
eral, the coefficients were lower than the results of the
relative frequencies of conspicuous indicators. All confi-
dence intervals overlapped with each other.
Kendall’s coefficient of concordance for all four groups
was 0.633 (p < 0.001). Only three hospitals (E, I, K) con-
sistently placed in either the superior or inferior half of
Table 3 Rank based on the relative frequency of
conspicuous indicator results for each hospital
HELIOS comparison groups
rank
3 M PSI SP Mort SP LOS
Hospital Minimum Maximum Mean Rank Rank Rank
A 10 10 10.00 6 10 6
B 5 8 6.50 4 5 3.5
C 2 6 3.50 10 6 9
D 2 5 3.50 3 9 3.5
E 1 8 5.17 1 1.5 1
F 2 5 3.33 8 4 5
G 8 9 8.67 5 7 7
H 4 7 5.33 7 3 10
I 6 9 7.83 9 8 8
K 1 2 1.17 2 1.5 2
Rank 1 denotes the best result, and 10 the worst result.
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Figure 1 Range of ranks for weaknesses and strengths. Hospitals on the horizontal axis, ranks on the vertical axis.
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and Figure 1). Three hospitals ranked first or second at
least once (hospitals B, E and K), whereas four ranked
last or second to last at least once (hospitals A, C, H
and I). The median difference between the lowest and
highest rank per hospital was four, with a minimum of
one and a maximum of seven. The range of the relative
frequency of best practice indicator results per compari-
son group was at least 38.9% (3 M HELIOS, minimum
29.9%, maximum 68.8%) and as high as 93.1% (3 M PSI,
6.9%, 100%).
Comparing the ranks in weaknesses to the ranks in
strengths, two hospitals stable ranked in either the
superior or the inferior half of the group independent of
the comparison group, with hospital K stably positioned
in the superior group, and hospital I in the inferior
group.
Discussion
There was substantial correlation between the quality
indicator sets analyzed in this study with respect to
identification of the weaknesses of the ten hospitals. As
expected, indicator sets differing only in their reference
values showed significant and substantial correlation
coefficients for most of the pairs. Only the results
obtained with the proprietary definition of confidence
limits by InMed (InMed HELIOS assessment) were not
concordant with the results from either 3 M group. The
companies’ interpretations of the indicator definitions
seem to be more relevant than the different ways in
which they define the reference values. Therefore, indi-
cator definitions should be made publicly available, non-
ambiguous and simple to calculate. Furthermore, arbi-
trary definitions of established statistical concepts, as is
the case with the new definition of confidence limits by
InMed, should be firmly rejected.
The mortality analysis using groups defined by Disease
Stages showed a strong correlation with two of the indi-
cator sets based on the HELIOS approach. Interestingly,
the only significant correlation of PSI was with an analy-
sis based on LOS. One can question whether the
adverse events identified by the PSI are more closely
related to LOS than to mortality, as represented by the
other indicator sets. This might be a “chicken or the
egg” type of dilemma since a longer LOS increases the
risk of adverse events, including death, but only adverse
events other than death increase LOS. The analysis did
not identify a favorite candidate for the detection of
weaknesses. Instead, the HELIOS indicator set and SP
Mort, on the one hand, and the PSI and SP LOS, on the
other, might be exchangeable. The few non-overlapping
confidence intervals supported the notion of different
degrees of concordance between the nine groups of
indicator sets.
There was also a substantial correlation between the
quality indicator sets identifying the strengths of a hos-
pital. In particular, the correlations between PSI and the
assessment of LOS and between PSI and mortality
based on Disease Stages were significant. Accordingly,
use the PSI may be appropriate if the goal is to identify
Table 4 Correlation coefficients for the relative frequency of best practice indicator results
3 M HELIOS 3 M PSI SP Mort SP LOS
3 M HELIOS Coefficient 0.372
(-0.336-0.812)
0.576
(-0.084-0.885)
0.310
(-0.397-0.786)
Sig. (2-sided) 0.290 0.082 0.383
3 M PSI Coefficient 0.646
(0.028-0.907)
0.669
(0.068-0.914)
Sig. (2-sided) 0.043 0.034
SP Mort Coefficient 0.488
(-0.204-0.855)
Sig. (2-sided) 0.153
SP LOS Coefficient
Sig. (2-sided)
The four groups consist of 10 hospitals each.
95% confidence interval in parentheses.
Table 5 Rank based on the relative frequency of best
practice indicators for each hospital
Hospital 3 M HELIOS 3 M PSI SP Mort SP LOS
A9 5 9 3
B6 4 4 2
C3 8 1 0 7
D7 7 8 4
E2 1 1 1
F4 6 3 6
G8 3 6 8
H5 1 0 5 9
I1 0 9 7 1 0
K1 2 2 5
Rank 1 denotes the best result, and 10 the worst result.
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dence intervals indicate a large degree of uncertainty in
the results. The robustness of the achieved rank is com-
parable to the results obtained for weaknesses, with a
slightly higher Kendall’s coefficient of concordance.
The comparison between two hospital ratings, “Hospi-
tal Compare” from the US Hospital Quality Alliance and
the “Best Hospitals” lists published by U.S. News and
World Report, did not result in a demonstration of con-
cordance [19]. The authors of that study calculated a
composite score for three conditions as well as a general
composite measure. The hospitals covered by “Hospital
Compare” were then assigned to quartiles according to
the score results. The 14 hospitals named in the Honor
Roll of Best Hospitals were equally distributed in the
quartiles (5-2-5-2 in 2004, 5-3-6-2 in 2005). Regarding
specific conditions, therew a sam i n o rc o r r e l a t i o n
between the 50 Best Hospitals and the composite mea-
sures of acute myocardial infarction and congestive
heart failure, but a minor negative correlation between
the 50 Best Hospitals and the composite measure of
community-acquired pneumonia. In contrast to the per-
formance measures in “Hospital Compare” and to the
indicator sets analyzed in this paper, the Best Hospital
rating system covers structural components and a hospi-
tal’s reputation based on a survey of physicians. Thus,
the results presented by Halasyamani and Davis might
reflect discrepancies between different players (profes-
sionals, health policy, patients), but they do not refute
the concordance between the different quality indicator
sets examined in our study.
In a simulation study, Jacobs et al. changed the
weights used for the construction of a composite mea-
sure [20]. The composite measure was based on ten per-
formance indicators covering a broad range of topics,
from patient outcome to staf f i n g .D a t aw e r eo b t a i n e d
from 117 English acute-care hospitals. Unlike our work,
Jacobs et al. did not draw any conclusions from a com-
parison of the results with reference values; they solely
concentrated on the relative position with respect to
both the value of the composite measure and the rank
of the hospital. They concluded that “although the rank-
ing of hospitals at extreme ends of the distribution are
reasonably secure - there is considerable uncertainty
about the ranking of more central observations,” Never-
theless, the correlation coefficients of 0.88 to 0.96
between the original composite measure and four alter-
natives strengthened their basic concordance.
To some extent, our results explain the conclusions
regarding the effectiveness of quality indicators pre-
sented in several reviews [4-8]. “Consistently inconsis-
tent” results [4] describe those of low robustness with
changing ranks. Nevertheless, the moderate concordance
between different sets, each offering its own view of
health care services, argues against a radical withdrawal
of the recent approaches. The situation is not as bad as
claimed by O’Leary et al. [8]. On an aggregate level,
adverse events were found to correspond with mortality,
and outcome with LOS. Due to the outcome orientation
of the analyzed sets, our results do not contribute to a
comparison of outcome and process measures.
The use of relative frequency as a composite measure
might raise concerns regarding the presented results.
There is indeed scant empirical but rather mostly prag-
matic evidence for this approach. It does not take into
account differences in an indicator’s severity, for exam-
ple. The overlapping confidence intervals in our analyses
point out the necessity of a study comprising a larger
sample of hospitals. From a statistical point of view, cor-
recting the individual indicator results for small num-
bers might be preferable. However, the indicator sets
use complete data, not samples. The AHRQ itself has
discussed composite measures concerning the AHRQ’s
indicator sets [21,22]. The attempt was made to obtain a
single value by combining the particular results of the
PSI [22]. Correlation analyses were previously performed
for single indicators [23] and for composite measures
with different indicator weights [20]. As far as the
authors know, the presented work is the first to perform
correlation analyses for different indicator sets.
Conclusions
In accordance with the limited empirical evidence, our
results confirm a moderate concordance between differ-
ent quality indicator sets on an aggregate level and
thereby justify the use of these indicator sets for quality
management purposes. The information gained from
application of the quality indicator sets to routine data
can guide hospital management in tailoring quality
improvement efforts. However, it is advisable to use
more than one set to obtain a complete overview of the
provided care, as each set offers a specific view with
complementary information on strengths and weak-
nesses. Nevertheless, we did not analyze the validity or
the effectiveness of the sets.
The evaluation of a hospital by a single approach can
be very unfair. For the huge group of mean performers,
rank depends mainly on the chosen approach, since the
quality indicator sets apparently show robust behavior
only for the best and worst hospitals. Thus, for a mean
performer, a combined assessment using quality indica-
tor sets with financial (e.g. pay for performance) or
accreditation (e.g. minimal hospital volume) issues is
not supported by our results. Patients must be aware
that the current rating systems based on quality indica-
tor sets do not yield a reliable picture of hospital quality.
Moreover, hospitals have the opportunity to improve
their ranking by selecting a more favorable indicator set
Stausberg et al. BMC Health Services Research 2011, 11:106
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Page 8 of 9of their choice. Much work has to be done to reach an
empirically proven application of quality indicator sets
that are independent of the support of health
professionals.
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